Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

STAAR Surgical Company - Common Stock (NQ:STAA)

27.74 +0.38 (+1.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about STAAR Surgical Company - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
STAAR Surgical to Report Third Quarter Results on October 30, 2024
From STAAR Surgical Company
Via Business Wire
Investors seeking growth at a reasonable cost should explore NASDAQ:STAA.
Looking for growth without the hefty price tag? Consider STAAR SURGICAL CO (NASDAQ:STAA). 
Via Chartmill
STAAR Surgical Experience Center Expands to Meet Growing Surgeon Demand
From STAAR Surgical Company
Via Business Wire
Analyst Scoreboard: 4 Ratings For Staar Surgical
 
Via Benzinga
Sidoti Events, LLC's Virtual September Small-Cap Conference
Via ACCESSWIRE
Analyst Expectations For Staar Surgical's Future
 
Via Benzinga
A Glimpse Into The Expert Outlook On Staar Surgical Through 4 Analysts
 
Via Benzinga
For those who appreciate growth without the sticker shock, NASDAQ:STAA is worth considering.
Don't overlook NASDAQ:STAA—a stock with solid growth prospects and a reasonable valuation. 
Via Chartmill
STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q2 2024
STAA stock results show that Staar Surgical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
STAAR Surgical Reports Second Quarter 2024 Results
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Second Quarter Results on August 7, 2024
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Participate in Canaccord Genuity 44th Annual Growth Conference
From STAAR Surgical Company
Via Business Wire
Expert Outlook: Staar Surgical Through The Eyes Of 5 Analysts
 
Via Benzinga
Analyst Scoreboard: 7 Ratings For Staar Surgical
 
Via Benzinga
Trump Media & Technology And Grindr Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 23 - June 29): Are These In Your Portfolio?
Top performers last week: Tempus AI +30%, Enovix Corp +29%, Grindr Inc +27.5%, Trump Media +18.33%, Credo Tech +18.3%, Tecnoglass Inc +17.9%, STAAR Surgical +16.55%, RXO Inc +16.22%, Global-E Online... 
Via Benzinga
Topics Artificial Intelligence Government
Staar Surgical Stock Earns RS Rating Upgrade
On Thursday, lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 87 from 77. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Top 4 Stocks With Notable Insider Buying
Insider buying might signal confidence and a bullish outlook for investors. Four stocks with heavy insider buying include DLTR, TALO, STAA, and RXO. 
Via MarketBeat
What 7 Analyst Ratings Have To Say About Staar Surgical
 
Via Benzinga
STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
From STAAR Surgical Company
Via Business Wire
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
 
Via Benzinga
STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q1 2024
STAA stock results show that Staar Surgical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
STAAR Surgical Reports First Quarter 2024 Results
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report First Quarter Results on May 7, 2024
From STAAR Surgical Company
Via Business Wire
Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier. 
Via Investor's Business Daily
Star Surgical Shines as U.S. Outlook Improves for 2024
STAAR Surgical is increasing its outlook and guidance as demand for its signature IOL procedure increases with an aging population 
Via MarketBeat
Apple To $210? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Eye Lens Maker STAAR Surgical Expects Q1 Sales To Beat Consensus
STAAR Surgical reports Q1 2024 net sales surpassing $77 million, with U.S. ICL sales hitting $5 million, the highest since FDA approval in 2022. CEO anticipates fiscal 2024 sales expected at the higher... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.